All Dana-Farber Cancer Institute articles
-
NewsBuilding protection against infectious diseases with nanostructured vaccines
Researchers have leveraged a recently developed highly versatile DNA origami nanotechnology that is both vaccine and adjuvant, named DoriVac, as an alternative to current vaccine platforms.
-
NewsVirus-based therapy boosts anti-cancer immune responses to brain cancer
A study has shown that a single injection of an oncolytic virus—a genetically modified virus that selectively infects and destroys cancer cells—can recruit immune cells to penetrate and persist deep within brain tumors.
-
NewsResearch links tumor bacteria to immunotherapy resistance in head and neck cancer
Two new studies reveal that elevated levels of bacteria in the tumor microenvironment suppress immune response, driving resistance to immunotherapy in patients with head and neck squamous cell carcinoma.
-
NewsCombining laboratory techniques yields wealth of information about deadly brain tumors
In a new study, researchers injected into the tumor a virus aimed at killing glioblastoma cells. Surgeons took tumor tissue samples and ran them through multiple advanced laboratory techniques to demonstrate that even small tissue samples can yield additional insights.
-
NewsGut bacteria engineered to act as tumor GPS for immunotherapies
Cancer researchers have engineered gut derived E. coli bacteria to express immune-activating cytokines on their surfaces, with the idea that the bacteria would move into tumors and induce potent immune responses.
-
NewsNovel compound protects against infection by virus that causes COVID-19
Compounds that obstruct the “landing gear” of a range of harmful viruses can successfully protect against infection by the virus that causes COVID-19.
-
NewsBoston Children’s Hospital receives a contract of up to $9 million to improve flu vaccines
The Precision Vaccines Program (PVP) at Boston Children’s Hospital has been awarded a contract from NIAID to develop a small molecule adjuvant to enhance the effectiveness of flu vaccines.